BJOG : an international journal of obstetrics and gynaecology
-
Ordinary meta-analyses indicate that magnesium sulphate (MgSO4 ) treatment in women at imminent risk for preterm delivery decreases the offspring's risk of cerebral palsy (CP). However, repetitive testing of cumulative data calls for statistical caution, e.g. by trial sequential analysis (TSA), for which there are previously insufficient samples to draw a firm conclusion. Recently, a randomised controlled trial (RCT) provided additional data that potentially increased the sample size such that a new TSA might detect a statistically significant effect. ⋯ Antenatal magnesium sulphate decreases the risk of cerebral palsy in children born preterm.
-
To investigate the mental status of pregnant women and to determine their obstetric decisions during the COVID-19 outbreak. ⋯ The COVID-19 outbreak increased pregnant women's anxiety and affected their decision-making.